YHR138C Antibody

What is YHR138C and why is it of interest to researchers?

YHR138C is an uncharacterized protein found in Saccharomyces cerevisiae (Baker's yeast, strain 204508/S288c) that has been implicated in stress response pathways. Based on gene expression analyses, YHR138C shows significant upregulation (1.263-fold change) during stress conditions, suggesting its involvement in cellular adaptation mechanisms . The protein has gained research interest due to its potential role in stress response pathways and its appearance in studies investigating SUMO chain function in chromatin organization. Understanding YHR138C function could provide insights into fundamental cellular processes in yeast and potentially in higher eukaryotes through conserved pathways.

What types of YHR138C antibodies are currently available for research?

Currently, polyclonal antibodies against YHR138C are commercially available for research purposes. Specifically, rabbit anti-Saccharomyces cerevisiae YHR138C polyclonal antibodies have been developed for research applications . These antibodies are generated through antigen-affinity purification methods and are provided as IgG isotype antibodies. While monoclonal antibodies may offer greater specificity for some applications, the current literature primarily references polyclonal antibodies for YHR138C detection, likely due to the limited characterization of this protein and relatively narrow research focus.

What are the recommended applications for YHR138C antibodies?

YHR138C antibodies have been validated for several experimental applications, including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) techniques . These applications are particularly useful for detecting and quantifying YHR138C protein expression in yeast cell extracts. Western blotting can help researchers monitor changes in YHR138C expression levels during different growth phases or stress conditions, while ELISA provides quantitative measurement capabilities. Developing robust protocols for these applications is essential for generating reliable data, especially when studying proteins that may be expressed at low levels, as targeted proteomics approaches have shown the ability to detect proteins expressed below 50 copies/cell in yeast total cell lysates .

How should researchers prepare yeast samples for optimal YHR138C detection?

Sample preparation is critical for successful detection of YHR138C protein. For optimal results, researchers should consider the following methodological approach: First, harvest yeast cells during appropriate growth phases, particularly during stress conditions when YHR138C expression may be elevated. Cell lysis should be performed using methods that preserve protein integrity, such as mechanical disruption with glass beads in the presence of protease inhibitors. Given that YHR138C may be expressed at relatively low levels, sample concentration or enrichment steps might be necessary. Clarifying cell lysates through centrifugation and quantifying total protein content allows for standardized loading in subsequent immunodetection applications. For Western blotting, proteins should be transferred to appropriate membranes (PVDF or nitrocellulose) followed by blocking with non-fat milk or BSA before antibody incubation according to manufacturer's recommendations.

How can researchers optimize Western blot protocols for low-abundance YHR138C detection?

Detecting low-abundance proteins like YHR138C requires optimization of standard Western blot protocols. Recent advancements in proteomics have demonstrated that targeted approaches can detect proteins expressed at single-digit copies per cell in yeast extracts . To optimize YHR138C detection, researchers should consider: (1) Increasing protein loading (50-100 μg total protein) while maintaining good resolution; (2) Utilizing high-sensitivity detection systems such as enhanced chemiluminescence (ECL) or near-infrared fluorescence; (3) Optimizing antibody concentrations through titration experiments (typically starting at 1:500-1:1000 dilutions for primary antibodies); (4) Extending primary antibody incubation to overnight at 4°C to enhance binding to low-abundance targets; (5) Incorporating signal enhancement systems such as biotin-streptavidin amplification; and (6) Using longer exposure times during imaging, balanced against increased background signal. Additionally, researchers should consider sample enrichment through immunoprecipitation prior to Western blotting for extremely low-abundance situations.

What experimental approaches can effectively link YHR138C to specific cellular pathways?

Understanding YHR138C's role in cellular pathways requires integrative experimental strategies. Based on available research data, YHR138C has been linked to stress response pathways , suggesting several effective experimental approaches. Researchers should consider:

• Gene expression correlation analysis: Compare YHR138C expression patterns with known stress response genes across different conditions. YHR138C shows a 1.263-fold change in expression during stress conditions, placing it among the top regulated genes .

• Protein-protein interaction studies: Utilize YHR138C antibodies for co-immunoprecipitation followed by mass spectrometry to identify interaction partners.

• Genetic interaction screening: Systematic genetic interaction assays using the yTHC (yeast Tet-promoter Hughes Collection) to identify functional relationships .

• Phenotypic analysis of YHR138C-depleted strains: Assess sensitivity to cell wall stressors like Calcofluor White, similar to screens conducted for essential genes in yeast cell wall integrity .

• Localization studies: Use fluorescently-tagged YHR138C or immunofluorescence with YHR138C antibodies to track subcellular localization changes during stress conditions.

• Chromatin immunoprecipitation (ChIP): If YHR138C has potential roles in chromatin regulation, as suggested by its appearance in SUMO chain function studies .

These approaches should be combined for a comprehensive understanding of YHR138C function.

How can researchers validate the specificity of YHR138C antibodies in experimental systems?

Validating antibody specificity is crucial for obtaining reliable results, particularly for poorly characterized proteins like YHR138C. A rigorous validation approach should include:

• Positive and negative controls: Use wild-type yeast expressing YHR138C as a positive control and YHR138C deletion strains (if viable) or knockdown strains as negative controls.

• Western blot analysis: Verify that the antibody detects a band of the expected molecular weight for YHR138C.

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before Western blotting or immunostaining to confirm signal specificity.

• RNA interference validation: In systems where applicable, knockdown YHR138C expression and confirm corresponding reduction in antibody signal.

• Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry to confirm the identity of the pulled-down protein.

• Cross-reactivity testing: Test the antibody against closely related proteins or in non-yeast systems where YHR138C homologs might exist.

• Epitope mapping: Determine which regions of YHR138C are recognized by the antibody to assess potential cross-reactivity risks.

Thorough validation ensures experimental findings are attributable to the target protein rather than non-specific interactions.

How does YHR138C relate to SUMO chain function and chromatin organization?

YHR138C has been identified in studies investigating SUMO (Small Ubiquitin-like Modifier) chain function in yeast, particularly in relation to chromatin organization. SUMO modification plays crucial roles in various cellular processes, and SUMO chains specifically impact chromatin structure maintenance . YHR138C appears in Table 1 of a comprehensive study of proteins affected by SUMO chain disruption and shows significant expression changes (1.263-fold increase) in smt3 allR mutant strains that are defective in SUMO chain assembly . This suggests YHR138C may be regulated by or involved in SUMO-dependent processes. The connection between YHR138C and chromatin organization opens research avenues for investigating its potential role in DNA replication, repair, or transcriptional regulation. Researchers utilizing YHR138C antibodies could design chromatin immunoprecipitation (ChIP) experiments to determine if YHR138C associates with specific genomic regions, potentially in a SUMO-dependent manner.

What is known about YHR138C in the context of stress response and cellular adaptation?

YHR138C has been implicated in stress response pathways based on its expression profile during cellular stress conditions. In comprehensive studies of yeast stress adaptation, YHR138C shows significant upregulation (1.263-fold change) during stress conditions , suggesting it plays a role in cellular adaptation mechanisms. The protein appears in groupings associated with stress response elements in gene expression analyses. Interestingly, smt3 allR yeast mutants, which show altered YHR138C expression, exhibit phenotypes reminiscent of inappropriate activation of environmental stress responses, including:

• Increased mitochondrial volume and metabolic activity

• Elevated oxygen consumption rates (more than fourfold increase)

• Fragmented vacuoles

• Increased intracellular glycerol concentrations (more than twofold increase)

• Thicker cell walls

These phenotypic characteristics suggest YHR138C may function in pathways connecting SUMO modification to stress adaptation. Researchers can utilize YHR138C antibodies to monitor protein expression, modification state, and localization changes during various stress conditions to further elucidate its function.

How can selected reaction monitoring (SRM) enhance YHR138C protein detection and quantification?

Selected reaction monitoring (SRM) represents a cutting-edge approach for detecting and quantifying low-abundance proteins like YHR138C in complex samples. This targeted proteomics technique offers significant advantages over traditional methods:

SRM can detect proteins expressed at extremely low levels (below 50 copies/cell) in total yeast digests, and potentially even at single-digit copies/cell levels . This sensitivity is particularly valuable for studying YHR138C, which may be expressed at low levels under normal conditions and upregulated during stress.

The technique allows consistent measurement of proteins spanning the entire abundance range in yeast, enabling researchers to monitor YHR138C alongside highly expressed proteins . The table below illustrates the range of protein detection possible with SRM:

For YHR138C research, SRM offers precise quantification across multiple samples and experimental conditions with high reproducibility. Researchers can develop specific SRM assays targeting unique peptides from YHR138C, enabling absolute quantification when combined with isotopically labeled reference peptides.

What are the experimental challenges in studying YHR138C and how can they be addressed?

Studying uncharacterized proteins like YHR138C presents several experimental challenges that researchers should anticipate and address:

• Low abundance detection: YHR138C may be expressed at low levels under standard conditions. This challenge can be addressed through sample enrichment techniques, sensitive detection methods like SRM , or inducing expression through appropriate stress conditions known to upregulate YHR138C.

• Functional redundancy: YHR138C may share functional redundancy with other proteins, masking phenotypes in single-gene studies. Researchers should consider combinatorial gene disruption approaches or conditional depletion systems like those used in yTHC collection studies .

• Condition-specific expression: YHR138C's function may be relevant only under specific conditions. Experimental designs should include various stress conditions, particularly those affecting cell wall integrity or triggering environmental stress responses .

• Protein-protein interaction detection: For uncharacterized proteins, identifying interaction partners is crucial. Beyond standard immunoprecipitation, researchers should consider proximity-dependent labeling approaches (BioID, APEX) or crosslinking strategies to capture transient interactions.

• Subcellular localization: Determining localization can provide functional insights. For YHR138C, researchers should employ both antibody-based immunofluorescence and fluorescent protein tagging approaches, comparing results to rule out tagging artifacts.

• Post-translational modifications: YHR138C may be subject to modifications, particularly SUMO-related modifications. Multiple detection methods, including modification-specific antibodies and mass spectrometry approaches, should be employed.

Addressing these challenges requires integrative approaches combining genetic, biochemical, and cell biological techniques.

How can YHR138C antibodies contribute to cell wall integrity research in yeast?

YHR138C antibodies can serve as valuable tools in cell wall integrity (CWI) research in yeast, particularly given emerging connections between stress responses and cell wall maintenance. The CWI pathway is a critical signaling network in yeast that responds to cell wall damage and triggers adaptive responses . Several methodological approaches utilizing YHR138C antibodies can advance this research area:

• Monitoring expression during cell wall stress: Researchers can use YHR138C antibodies to track protein expression changes during treatment with cell wall-interfering compounds like Calcofluor White (CW). Studies have shown that essential genes required for cell wall maintenance often display hypersensitivity to CW (40 μg/mL) .

• Investigating protein localization shifts: Immunofluorescence with YHR138C antibodies can reveal potential relocalization during cell wall stress, providing insights into functional roles.

• Examining post-translational modifications: Western blotting with YHR138C antibodies can detect mobility shifts indicating modifications potentially related to CWI pathway activation.

• Protein complex analysis: Immunoprecipitation with YHR138C antibodies followed by mass spectrometry can identify interaction partners potentially connecting YHR138C to known CWI pathway components.

• Chromatin association studies: If YHR138C plays a role in transcriptional regulation of cell wall genes, ChIP using YHR138C antibodies can map genomic binding sites.

These approaches can help determine whether YHR138C functions within the established CWI MAPK pathway or in parallel processes supporting cell wall maintenance during stress conditions.

What controls should be included when using YHR138C antibodies in immunoassays?

Implementing appropriate controls is essential for generating reliable data with YHR138C antibodies. Researchers should include the following comprehensive set of controls in immunoassay experiments:

• Positive controls:

  • Wild-type yeast lysates known to express YHR138C

  • Recombinant YHR138C protein (if available)

  • Samples from conditions known to upregulate YHR138C (stress conditions)

• Negative controls:

  • YHR138C deletion strains (if viable) or conditional depletion samples

  • Secondary antibody-only controls to assess non-specific binding

  • Pre-immune serum controls (especially for polyclonal antibodies)

• Specificity controls:

  • Peptide competition assays where antibody is pre-incubated with immunizing peptide

  • Isotype-matched irrelevant antibody controls

• Loading and transfer controls:

  • Housekeeping proteins (e.g., PGK1, TUB1) for Western blots

  • Total protein staining (Ponceau S, SYPRO Ruby) for membrane transfer verification

• Quantitation controls:

  • Standard curves using recombinant protein (if available)

  • Internal reference proteins with known expression levels

• Experimental condition controls:

  • Time course samples to capture dynamic changes

  • Dose-response samples for treatments affecting YHR138C expression

Including these controls enables confident interpretation of results and helps troubleshoot experimental issues. For publication-quality data, researchers should document all controls thoroughly and include representative images showing key controls alongside experimental data.

How can YHR138C research contribute to understanding fundamental cellular processes?

Research on YHR138C has significant potential to advance our understanding of fundamental cellular processes, particularly at the intersection of stress response pathways, SUMO modification systems, and chromatin organization. Several promising research directions emerge from current findings:

• Stress response integration: YHR138C's upregulation during stress conditions (1.263-fold change) positions it as a potential component in stress signaling networks. Future research can explore how YHR138C contributes to cellular adaptation across various stress types, potentially revealing new regulatory mechanisms.

• SUMO pathway connections: YHR138C's appearance in studies of SUMO chain function suggests it may be regulated by or function within SUMO-dependent processes. Investigating whether YHR138C is directly SUMOylated or interacts with SUMOylated proteins could reveal novel SUMO-dependent regulatory mechanisms.

• Chromatin dynamics: The connection to chromatin organization through SUMO chain studies opens avenues for exploring YHR138C's potential role in genome maintenance, DNA repair, or transcriptional regulation during stress.

• Cell wall integrity: Given the connections to cell wall maintenance pathways , YHR138C may represent a missing link between stress sensing and structural adaptations in fungal cells.

• Evolutionary conservation analysis: While currently characterized in yeast, identifying potential functional homologs in other organisms could expand the significance of YHR138C research to broader biological contexts.

Each of these research directions can benefit from the application of YHR138C antibodies in combination with cutting-edge proteomics, genomics, and cell biology approaches.

What emerging technologies could enhance future YHR138C antibody-based research?

Emerging technologies offer exciting possibilities for advancing YHR138C research beyond current methodological limitations:

• Single-cell proteomics: Adapting techniques like mass cytometry (CyTOF) or single-cell Western blotting for yeast cells could reveal cell-to-cell variation in YHR138C expression and modification states within populations.

• Proximity labeling proteomics: BioID or APEX2 fusion proteins could map the proximal proteome of YHR138C in living cells, identifying transient or weak interactions missed by conventional immunoprecipitation.

• CRISPR-based genomic tagging: While challenging in yeast, adapted CRISPR technologies enable precise endogenous tagging for live-cell imaging and functional studies without disrupting native regulation.

• Super-resolution microscopy: Techniques like STORM or PALM, when combined with YHR138C antibodies, could reveal previously undetectable subcellular localization patterns at nanometer resolution.

• Targeted protein degradation: Auxin-inducible degron (AID) systems adapted for yeast allow rapid, conditional depletion of YHR138C to study acute loss-of-function effects.

• Microfluidics-based single-cell analysis: Combining microfluidics with time-lapse microscopy and immunofluorescence enables tracking of YHR138C dynamics in individual cells across stress response timelines.

• Nanobody development: Developing YHR138C-specific nanobodies could improve imaging applications and enable novel functional perturbation approaches.

These technologies, particularly when integrated with existing antibody-based detection methods, can overcome current limitations in studying low-abundance, condition-specific proteins like YHR138C.